Reuters logo
BRIEF-Transgene H1 operating loss widens at 16.1 million euros
September 13, 2017 / 4:46 PM / 13 days ago

BRIEF-Transgene H1 operating loss widens at 16.1 million euros

Sept 13 (Reuters) - TRANSGENE SA:

* TRANSGENE: FIRST HALF-YEAR 2017 IN LINE WITH OUR OBJECTIVES: ALL CLINICAL PROGRAMS PROGRESSING AND NEW COLLABORATION AGREEMENTS SIGNED

* ‍CASH AND CASH EQUIVALENTS AS OF JUNE 30, 2017: EUR 43.9 MILLION, FINANCIAL VISIBILITY CONFIRMED TO END OF 2018​

* H1 OPERATING REVENUES EUR ‍​3.9 MILLION VERSUS EUR 5.3 MILLION YEAR AGO

* H1 COMPREHENSIVE NET LOSS EUR 18.3 MILLION VERSUS LOSS OF EUR 12.2 MILLION YEAR AGO

* IS ‍WELL PLACED TO PROGRESS ITS PROGRAMS THROUGH TO END OF 2018​

* H1 COMPREHENSIVE NET LOSS EUR 18.3‍​ MILLION VERSUS LOSS OF EUR 12.2 MILLION YEAR AGO

* EXPECTS 2017 CASH BURN TO BE AROUND EUR 30 MILLION

* H1 OPERATING LOSS EUR ‍​16.1 MILLION VERSUS LOSS OF EUR 10.7 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below